Your session is about to expire
← Back to Search
Beta Blocker
Propranolol for Prolonged Pregnancy (PROPEL Trial)
Phase 3
Waitlist Available
Led By Lisa Levine, MD, MSCE
Research Sponsored by Lisa Levine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from start of labor through delivery
Awards & highlights
PROPEL Trial Summary
This trial found that propranolol given to women in labor can help speed up the process and reduce the likelihood of needing a c-section.
PROPEL Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from delivery through hospital discharge, usually 2-4 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from delivery through hospital discharge, usually 2-4 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Mode of Delivery
Secondary outcome measures
Chorioamnionitis
Length of Labor
Maternal Morbidity
+2 morePROPEL Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: PropranololActive Control1 Intervention
IV Propranolol - 2mg; one possible repeat dose ≥2 hours later
Group II: PlaceboPlacebo Group1 Intervention
Normal saline placebo- 2 mL; one possible repeat dose ≥2 hours later
Find a Location
Who is running the clinical trial?
Lisa LevineLead Sponsor
Lisa Levine, MD, MSCEPrincipal Investigator - University of Pennsylvania
Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Pennsylvania Hospital
1 Previous Clinical Trials
2,300 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger